Tannin Capital’s Pfizer PFE Stock Holding History

Tannin Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$356K	Sell	14,784 -1,011	-6%	-$26.4K	0.23%	108
2026 Q1	$444K	Buy	15,795 +4,419	+39%	+$118K	0.32%	85
2025 Q4	$283K	Buy	+11,376	New	+$287K	0.25%	98

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Tannin Capital's PFE Position: Q2 2026 in Review

Tannin Capital reduced its Pfizer (PFE) stake by 6.4% in Q2 2026, selling an estimated $26.4K and leaving 14,784 shares worth $356K. The position accounts for 0.23% of the portfolio, ranked #108.

Tannin Capital first reported a position in PFE in Q4 2025 and has held it in 3 quarters since. The position peaked at $444K in Q1 2026. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Tannin Capital held 14,784 shares of Pfizer worth $356K as of Q2 2026.
Tannin Capital sold 1,011 Pfizer shares in Q2 2026, an estimated $26.4K.
Pfizer made up 0.23% of Tannin Capital's portfolio in Q2 2026, its #108 holding.
Tannin Capital first reported a position in Pfizer in Q4 2025 and has held it in 3 quarters since.
Tannin Capital's Pfizer position peaked at $444K in Q1 2026.
2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Tannin Capital's 13F filing for Q2 2026, filed 4 Aug 2026.